Inside informationEnglish
AB Science: Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 04/03/2025, 08:35
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 111692_20250304